S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Modern Day Options Trading For Beginners! (Ad)pixel
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Modern Day Options Trading For Beginners! (Ad)pixel
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Modern Day Options Trading For Beginners! (Ad)pixel
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Modern Day Options Trading For Beginners! (Ad)pixel
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Modern Day Options Trading For Beginners! (Ad)pixel
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Modern Day Options Trading For Beginners! (Ad)pixel
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Modern Day Options Trading For Beginners! (Ad)pixel
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Modern Day Options Trading For Beginners! (Ad)pixel
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
NASDAQ:MBII

Marrone Bio Innovations - MBII Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$0.80
$0.80
50-Day Range
$0.80
$0.80
52-Week Range
$0.55
$1.55
Volume
38 shs
Average Volume
919,497 shs
Market Capitalization
$145.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MBII stock logo

About Marrone Bio Innovations (NASDAQ:MBII) Stock

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

Receive MBII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marrone Bio Innovations and its competitors with MarketBeat's FREE daily newsletter.

MBII Stock News Headlines

Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
MBI: Body found in Forrest Co. identified
Marrone name goes away in sale to Bioceres
See More Headlines
Receive MBII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marrone Bio Innovations and its competitors with MarketBeat's FREE daily newsletter.

MBII Company Calendar

Last Earnings
11/10/2021
Today
3/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Agricultural Chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:MBII
Fax
N/A
Employees
153
Year Founded
N/A

Profitability

Net Income
$-16,550,000.00
Pretax Margin
-47.12%

Debt

Sales & Book Value

Annual Sales
$44.31 million
Book Value
$0.17 per share

Miscellaneous

Free Float
173,259,000
Market Cap
$145.56 million
Optionable
Not Optionable
Beta
0.36

Key Executives

  • Mr. Kevin R. Helash (Age 57)
    CEO & Director
    Comp: $416.64k
  • Dr. Pamela G. Marrone Ph.D. (Age 65)
    Founder, Advisor & Non-Employee Director
    Comp: $254.58k
  • Ms. Linda V. Moore (Age 75)
    Chief Compliance Officer, Chief Legal Officer & Sec.
    Comp: $316.74k
  • Mr. LaDon Johnson CPA
    CPA, Interim Chief Financial Officer
  • Dr. Amit Vasavada Ph.D. (Age 67)
    Sr. VP of Research Devel. & Chief Technical Officer
  • Andre Trepanier
    Director of Marketing
  • Mr. Barner Jones
    Director of National Sales & Account Management
  • Mr. Matti Tiainen (Age 33)
    Sr. VP of International Sales
  • Mr. Keith J. Pitts (Age 58)
    Sr. VP of Regulatory & Gov. Affairs and Chief Sustainability Officer













MBII Stock - Frequently Asked Questions

How were Marrone Bio Innovations' earnings last quarter?

Marrone Bio Innovations, Inc. (NASDAQ:MBII) posted its quarterly earnings data on Wednesday, November, 10th. The basic materials company reported ($0.03) EPS for the quarter, hitting the consensus estimate of ($0.03). The basic materials company earned $9.86 million during the quarter, compared to the consensus estimate of $10.79 million. Marrone Bio Innovations had a negative net margin of 47.07% and a negative trailing twelve-month return on equity of 70.87%. During the same period in the previous year, the firm posted ($0.04) earnings per share.

What other stocks do shareholders of Marrone Bio Innovations own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Marrone Bio Innovations investors own include Ekso Bionics (EKSO), Matinas BioPharma (MTNB), Bionano Genomics (BNGO), KushCo (KSHB), Enerplus (ERF), ADMA Biologics (ADMA), Great Panther Mining (GPL), Organigram (OGI), Aeterna Zentaris (AEZS).

What is Marrone Bio Innovations' stock symbol?

Marrone Bio Innovations trades on the NASDAQ under the ticker symbol "MBII."

What is Marrone Bio Innovations' stock price today?

One share of MBII stock can currently be purchased for approximately $0.80.

How much money does Marrone Bio Innovations make?

Marrone Bio Innovations (NASDAQ:MBII) has a market capitalization of $145.56 million and generates $44.31 million in revenue each year. The basic materials company earns $-16,550,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis.

How many employees does Marrone Bio Innovations have?

The company employs 153 workers across the globe.

How can I contact Marrone Bio Innovations?

Marrone Bio Innovations' mailing address is 1540 Drew Avenue, Davis CA, 95618. The official website for the company is www.marronebioinnovations.com. The basic materials company can be reached via phone at (530) 750-2800 or via email at ir@marronebio.com.

This page (NASDAQ:MBII) was last updated on 3/25/2023 by MarketBeat.com Staff